Best Emerging Markets ex-China ETF EU 2026: EXCH, EMXC

Compare top UCITS EM ex-China ETFs in 2026: iShares EXCH vs alternatives, TER, AUM, India weight, EU tax treatment, plus 100k EUR portfolio tilt example.

Best Emerging Markets ex-China ETF for EU Investors in 2026 Deep Dive

The "EM ex-China" exposure barely existed five years ago. Today it's one of the fastest-growing ETF categories globally, driven by a specific institutional and retail demand: investors who want the structural EM growth thesis (demographics, urbanisation, productivity catch-up) but who don't want the regulatory, geopolitical, or concentration risks of China.

The thesis is straightforward. Standard EM ETFs carry 25 to 30% China weight. If you have a separate (or zero) view on China, that weight is unintentional. EM ex-China lets you size China independently — overweight, underweight, or zero — while keeping the rest of the EM basket clean.

This deep dive compares the best UCITS EM ex-China ETFs in 2026, breaks down country composition (India, Taiwan, Korea, Brazil, Mexico, South Africa), walks through EU tax treatment across DE/FR/IT/ES/PL, and ends with a 100k EUR portfolio tilt example.

TL;DR

  • Top UCITS pick: iShares MSCI EM ex-China UCITS ETF (Acc) — ticker EXCH, ISIN IE000F3D2X86, TER 0.18%, AUM around 1.8 billion EUR, accumulating, MSCI EM ex-China index.
  • Runner-up: Amundi MSCI EM ex China UCITS ETF Acc — ISIN LU2533908945, TER 0.18%, AUM around 350 million EUR.
  • Use case: core EM allocation where you want to control China weight separately. Typical sizing 5 to 15% of equities, paired with a separate optional China position.

EM ex-China Market Overview

MSCI EM ex-China covers approximately 23 countries by index design but, in market-cap terms, the composition is highly concentrated. As of early 2026:

  • India: ~26%
  • Taiwan: ~22%
  • South Korea: ~16%
  • Brazil: ~6%
  • Saudi Arabia: ~5%
  • South Africa: ~4%
  • Mexico: ~3%
  • Indonesia: ~3%
  • Thailand: ~2%
  • United Arab Emirates: ~2%
  • Poland, Malaysia, Philippines, Turkey, Chile, Greece, others: ~11% combined

So in practice, EM ex-China is dominated by India + Taiwan + Korea (~64% combined). If you don't have a view on those three markets, you don't have a view on this ETF. Brazil and the Latin American block are non-trivial but not the main story.

Sector composition is markedly different from standard EM. With China removed, the index is more tech-heavy (Taiwan TSMC + Samsung + SK Hynix push IT to ~25%), more financials-heavy (India banks + Brazil Itau push financials to ~22%), and less consumer-discretionary heavy (without Alibaba/Tencent/Meituan, that sector drops to ~10%).

Real GDP combined across the EM ex-China block: roughly 18 trillion USD. Population: ~4 billion. Median age varies wildly (India 29, Korea 44, Taiwan 43, Brazil 33).

Top UCITS EM ex-China ETFs Compared

The UCITS EM ex-China universe is small. iShares dominates AUM by a wide margin, with Amundi, BNP Paribas, and Xtrackers providing alternatives.

1. iShares MSCI EM ex-China UCITS ETF (Acc) — EXCH / EMXC (UCITS)

  • ISIN: IE000F3D2X86
  • Issuer: iShares
  • TER: 0.18%
  • AUM: around 1.8 billion EUR
  • Replication: physical (sampled)
  • Distribution: accumulating
  • Listings: Xetra (EXCH), London, SIX, Borsa Italiana
  • Holdings: ~660 stocks across ~23 countries

The reference product for the category. Largest AUM, tightest spreads, accumulating. The default choice for most EU retail.

2. Amundi MSCI Emerging Markets ex China UCITS ETF Acc — EMXC

  • ISIN: LU2533908945
  • Issuer: Amundi
  • TER: 0.18%
  • AUM: around 350 million EUR
  • Replication: physical
  • Distribution: accumulating

Identical TER to iShares, smaller AUM. Slightly wider spreads but functionally equivalent. Good alternative when broker fee schedules favour Amundi products.

3. Xtrackers MSCI EM ex China UCITS ETF 1C — XCEC

  • ISIN: LU2596974663
  • Issuer: DWS (Xtrackers)
  • TER: 0.20%
  • AUM: around 300 million EUR
  • Replication: physical (sampled)
  • Distribution: accumulating

Slightly higher TER than iShares and Amundi. Best for investors with existing Xtrackers preference at their broker.

4. BNP Paribas Easy MSCI Emerging ex Controversies (with China minimization)

  • Smaller, more niche product. ESG-screened.
  • TER around 0.45%.
  • Less suitable as core EM ex-China exposure but worth knowing about for ESG-mandated investors.

5. iShares MSCI Emerging Markets ex-China Climate Aware UCITS ETF

  • ISIN: IE0003LCV0J1
  • TER: 0.20%
  • ESG-tilted EM ex-China with a climate transition score overlay
  • AUM around 150 million EUR

For investors who want EM ex-China with sustainability overlay. Performance has tracked the standard MSCI EM ex-China index within ~50 bps annualised.

Not EM ex-China per se, but worth comparing: SPDR's full MSCI EM at TER 0.18%, AUM ~3 billion EUR. The structural choice is "EM with China or EM ex-China." If you don't want China, EXCH is the answer; if you're happy with market-cap China weight, full EM (EIMI / SPDR EM) is cheaper to express.

Holdings Breakdown

MSCI EM ex-China top 10 (early 2026, approximate weights):

# Stock Country Sector Weight
1 TSMC Taiwan IT 10.5%
2 Samsung Electronics Korea IT 5.5%
3 Reliance Industries India Energy 3.0%
4 HDFC Bank India Financials 2.7%
5 Infosys India IT 2.0%
6 SK Hynix Korea IT 1.9%
7 ICICI Bank India Financials 1.9%
8 TCS India IT 1.5%
9 Bharti Airtel India Comm. 1.2%
10 Mediatek Taiwan IT 1.1%

Top 10 = ~31% of the index. TSMC alone is over 10% — single-stock concentration is real and arguably the biggest hidden risk of this category.

Sector breakdown (MSCI EM ex-China):

  • IT: 25%
  • Financials: 22%
  • Consumer Discretionary: 10%
  • Materials: 8%
  • Energy: 7%
  • Industrials: 7%
  • Consumer Staples: 6%
  • Comm. Services: 6%
  • Healthcare: 4%
  • Utilities: 3%
  • Real Estate: 2%

Market cap split: large 85%, mid 15%, no small caps (MSCI Standard EM doesn't include small caps; for that use MSCI EM IMI ex-China where available).

Risk Angles

Taiwan concentration and geopolitics. TSMC = 10%+ of the index. A Taiwan Strait crisis would hit this ETF disproportionately versus broad EM (which has TSMC at ~8%) and versus MSCI World (TSMC ~0%). This is the largest single risk factor of EM ex-China exposure.

India valuation. India is 26% of the index at forward P/E ~23x. If India de-rates, EM ex-China takes a meaningful hit. Detail in the India deep dive on this site.

Korea governance. Korea has a "Korea discount" structurally — chaebol governance issues, succession risk at Samsung. Korean Value Up program from 2024-2025 has begun to address this but progress is slow.

Currency. Mixed EM FX bag — INR, TWD, KRW, BRL, MXN, ZAR. Aggregate FX drag against EUR has been roughly 1.5 to 2.5% annualised long-term. No EUR-hedged EM ex-China UCITS exists in 2026.

Regulatory. Multiple jurisdictions, multiple regimes. Generally less acute than China but Brazil, Turkey, and South Africa have had market-disruptive policy episodes within the last decade.

Performance Comparison

Trailing 5-year EUR returns to early 2026:

Index Annualised Return
MSCI EM ex-China approx. 8.5%
MSCI EM (with China) approx. 4.5%
MSCI India approx. 13.5%
MSCI World approx. 11.4%
MSCI ACWI approx. 10.2%

EM ex-China substantially outperformed standard MSCI EM over this stretch because China was the major drag. This is precisely why the category exists. Over longer windows (15+ years), the divergence is smaller because pre-2021 China was actually a tailwind to standard EM.

Correlation of MSCI EM ex-China to MSCI World (10-year monthly): ~0.78. Slightly lower than standard EM, slightly higher than EM with China.

Tax Treatment Across the EU

Germany. Teilfreistellung 30% applies. Effective CGT ~18.46%. Vorabpauschale on accumulating.

France. Not PEA-eligible. CTO at 30% PFU, or assurance-vie.

Italy. 26% flat CGT.

Spain. 19% to 28% progressive CGT on realisation.

Poland. Belka 19% on realisation. Accumulating share class shields annual events. IKE/IKZE wrappers fully shield. PIT-38 self-reporting for foreign-domiciled brokerage holdings.

When an EM ex-China Tilt Makes Sense

  • You want EM exposure but have a negative or zero view on China. This is the literal use case.
  • You hold a separate China position. Pair EM ex-China with a sized China ETF (5 to 7%) for full deliberate control over both exposures.
  • You're concerned about China geopolitical risk. Removing China removes ~30% of standard EM's geopolitical-sensitivity.
  • You believe India + Taiwan + Korea will outperform China structurally. Reasonable thesis given demographic and governance differentials.

When It Doesn't

  • You want pure EM beta. Then use standard EM (EIMI / iShares Core MSCI EM IMI) which is cheaper at 0.18% TER, same as EXCH but with full EM coverage.
  • You believe China is a contrarian buy. Then hold full EM (with market-cap China) and possibly overweight China separately.
  • You're not sure why you'd own EM at all. Don't tilt. Hold VWCE / VEVE.
  • You can't tolerate Taiwan concentration risk. EXCH has TSMC at 10%+; this is more concentrated than full EM.

Broker Availability

Broker Available products Notes
Trade Republic iShares EXCH, Amundi EM ex China Savings plans available
Scalable Capital EXCH and main alternatives Free savings plans
DEGIRO EXCH and Amundi versions Often on core selection
Interactive Brokers Full UCITS EM ex-China universe Best for large tickets
mBank Brokers (https://www.mbank.pl) iShares EXCH on Xetra Polish desktop
BOSSA (https://bossa.pl) iShares EXCH via foreign markets module IKE/IKZE compatible

For Polish investors who want IKE/IKZE shelter, EXCH at https://bossa.pl or https://www.mbank.pl is the practical default. Trade Republic and IBKR offer wider international product range but no IKE/IKZE wrapper. Revolut (https://revolut.com/referral/?referral-code=rafa9jcta!MAR1-26-AR) does not currently offer UCITS EM ex-China products via fractional shares; the EM ex-China US ETF (EMXC ticker, iShares MSCI EM ex-China non-UCITS) is generally inappropriate for EU retail.

Worked Example: 100k EUR + 10% EM ex-China Tilt over 20 Years

Portfolio A: 100% VWCE. 7% real EUR → 387k EUR after 20 years.

Portfolio B: 90% VWCE + 10% iShares EXCH. Assume EM ex-China delivers 8% annualised real EUR (slight premium to global, reflecting India + Taiwan structural thesis). Blended portfolio: 7.10% → 394k EUR. ~7k EUR ahead.

Portfolio C (the deliberate barbell): 85% VWCE + 10% EXCH + 5% China. Assume China delivers 6% annualised real EUR (contrarian mean-reversion). Blended portfolio: 7.05% → 392k EUR.

The barbell approach (C) gives you the explicit decomposition: global core + EM growth ex-China + a small contrarian China position. If China outperforms, you participate; if it doesn't, the 5% allocation is sized so the drag is modest.

For Polish savers running a 25-year IKE accumulation: a deliberate EM ex-China + small China structure is materially more controllable than a blanket EM exposure. You can dial each lever based on changing views without selling everything.

The Freenance approach turns these allocation decisions into Financial Freedom Runway (FFR) outcomes — months and years of cost-of-living covered, not abstract return numbers. A 7k EUR endpoint gap over 20 years is small in CAGR terms but real in FFR terms: 3 to 4 months of additional runway on a typical Polish FI budget, free for the cost of a smarter EM allocation.

Polish Reader Angle

For Polish investors, the iShares EXCH accumulating share class is the standard. Xetra-listed in EUR, available via https://bossa.pl foreign-markets module, https://www.mbank.pl broker, IBKR, Trade Republic, and most Polish-accessible international brokers.

Belka 19% applies on realisation outside the wrapper. Inside IKE (limit ~23,500 PLN in 2026) or IKZE (~9,400 PLN), gains are sheltered. EXCH is well-suited to long-horizon IKE accumulation because the accumulating share class avoids annual taxable events.

Currency triangulation: PLN → EUR funding → multi-EM-currency basket. Net FX drag in EUR terms has been ~1.5 to 2.5% annualised; PLN-EUR adds another layer. Long-horizon investors typically accept this rather than try to time it.

FAQ

Q: EXCH vs EIMI — which should I hold? A: EIMI (iShares Core MSCI EM IMI) holds full EM including China and includes small caps. EXCH excludes China and large cap only. If you have no specific view on China, EIMI is simpler. If you want China sized independently (or excluded), EXCH is the right tool.

Q: What's the TSMC concentration risk in practice? A: TSMC = 10%+ of EXCH. A Taiwan Strait military crisis would impair TSMC severely and the broader Taiwan market. EXCH would underperform broad EM and World significantly in such a scenario.

Q: Should I pair EXCH with a China ETF? A: That's the design pattern. EXCH + sized China ETF (3 to 7%) = full deliberate EM control. Without the China sleeve, you have zero China exposure (other than indirect VIE through some EM names).

Q: Is EXCH PEA-eligible? A: No. PEA requires EU/EEA exposure.

Q: What's the structural difference vs EM ex-China small cap? A: EXCH is large/mid cap only (MSCI Standard methodology). MSCI EM IMI ex-China would add small caps — a few small UCITS products exist but AUM is limited. For most retail, EXCH is sufficient.

Q: How does EXCH compare to a multi-country basket I could build myself? A: Building India + Taiwan + Korea + Brazil + Saudi separately would replicate roughly 75% of EXCH for higher cost and rebalancing complexity. EXCH at 0.18% TER is a strong default unless you want explicit country control.

Sources

  • MSCI index methodology (MSCI EM ex-China, MSCI EM IMI ex-China)
  • iShares, Amundi, Xtrackers, BNP Paribas official factsheets and KIID
  • Country exchange data: NSE (India), TWSE (Taiwan), KRX (Korea), B3 (Brazil), Saudi Tadawul
  • National tax authority guidance (BMF Germany, Agenzia delle Entrate Italy, AEAT Spain, KIS Poland)
  • IMF World Economic Outlook 2026 (GDP and population data)

Disclaimer

This article is educational and does not constitute investment advice under Polish or EU regulations. Past performance is not a reliable indicator of future returns. EM ex-China exposure carries market, currency, geopolitical, and concentration risk (particularly Taiwan single-issuer exposure). Tax rules vary by jurisdiction and individual circumstances; consult a licensed advisor. Freenance does not provide personalised investment advice and is not authorised by KNF or any other competent authority as an investment firm.

Want full control over your finances?

Try Freenance for free
Start today

Your path to financial freedomstarts here

Join thousands of investors who use Freenance to manage their personal finances.

Start for free
14 days free
No credit card
256-bit encryption